| Trial ID: | L0739 |
| Source ID: | CTRI/2019/06/019926
|
| Associated Drug: |
Rosuvastatin
|
| Title: |
COMPARATIVE EVALUATION OF EFFICACY AND SAFETY OF METFORMIN AND GLIMEPIRIDE WITH CONCOMITANT ROSUVASTATIN IN PATIENTS OF NON ALCOHOLIC FATTY LIVER DISEASE WITH COEXISTENT TYPE 2 DIABETES MELLITUS
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
|
| Interventions: |
Intervention1: Metformin and Rosuvastatin: Metformin (1 gm BD) and<br>Rosuvastatin (10 mg OD) for a duration of 3 months in patients of NAFLD concomitant with newly diagnosed Type 2 Diabetes Mellitus <br><br>Control Intervention1: Glimepiride and Rosuvast
|
| Outcome Measures: |
Effect on histological features of ultrasound liver in patients at the end of treatment <br/ ><br>Timepoint: 0 and 90 daysEffect on Aminotransferase levels at the end of the treatmentTimepoint: 0,30,60,90 days
|
| Sponsor/Collaborators: |
nil
|
| Gender: |
--
|
| Age: |
nannan
|
| Phases: |
Post-market
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Randomized, Parallel Group, Active Controlled Trial<br> Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Not Applicable Blinding and masking:Open Label
|
| Start Date: |
28/06/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
24 November 2021
|
| Locations: |
India
|
| URL: |
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=34799
|
